Keep up with Natera Inc. and more.
Natera, Inc. is a global leader in cell-free DNA (cfDNA) testing and diagnostics. The company develops cutting-edge genetic testing solutions to advance patient care in oncology, women's health, and organ health. Natera’s portfolio includes clinically validated tests such as Panorama®, a non-invasive prenatal test for chromosomal abnormalities; Horizon™, a carrier screening tool for inherited conditions; Signatera™, a personalized assay for detecting molecular residual disease in cancer; and Prospera™, which monitors organ transplant rejection through donor-derived cfDNA. Supported by over 250 peer-reviewed studies, Natera’s tests integrate advanced molecular biology, AI, and bioinformatics to deliver exceptional accuracy. Operating CAP-accredited and CLIA-certified labs, Natera is committed to making personalized genetic testing a standard of care, empowering earlier and more targeted medical interventions for improved outcomes.
Discover the world's most disruptive early stage companies with 40,000+ investors.
The markets and trends that matter, made simple.
![Amazon](https://cdn.prod.website-files.com/66e35aca0b950055d2ec3b88/66e516c1807e91c5b0c9b58a_67189f2eb4d65aead3d46bf077b95c9bf08307cb19a552d6fb3baa3789cb9348.png)
![Wells Fargo](https://cdn.prod.website-files.com/66e35aca0b950055d2ec3b88/66e516c2807e91c5b0c9b5a1_6bfc4e8bb76cca4490e5a91cc79b9a7b00ebe05ed820ab24420e1c6324a4b877.png)
![Coinbase](https://cdn.prod.website-files.com/66e35aca0b950055d2ec3b88/66e4c6cdd0cc6e0082e574fb_Coinbase%20logo.png)
![CRAFT Ventures](https://cdn.prod.website-files.com/66e35aca0b950055d2ec3b88/66e35aca0b950055d2ec3bfc_CraftVentures.png)
Join top talent at the world's most respected institutions, companies, and venture capital funds.